Overcoming the Challenges of Primary Tumor Management in Patients With Metastatic Colorectal Cancer Unresectable for Cure and an Asymptomatic Primary Tumor

Diseases of the Colon and Rectum

Volumn 57, Issue 6, 2014, Pages 679-686

  Matsumoto, Takuya ^a   Hasegawa, Suguru ^a   Matsumoto, Shigemi ^b   Horimatsu, Takahiro ^b   Okoshi, Kae ^a   Yamada, Masahiro ^a   Kawada, Kenji ^a   Sakai, Yoshiharu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Asymptomatic; Colorectal cancer; Competing risk; Stage IV; Symptom directed surgery; Unresectable

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; OXALIPLATIN; UFT; PLATINUM COMPLEX;

ADULT; AGED; ASYMPTOMATIC DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLONOSCOPY; CONFERENCE PAPER; CONTROLLED STUDY; ENTEROSTOMY; FEMALE; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OBSERVATIONAL STUDY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; ADENOCARCINOMA; ASYMPTOMATIC DISEASES; COLORECTAL NEOPLASMS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SECONDARY;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASYMPTOMATIC DISEASES; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84901746678     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000025     Document Type: Conference Paper

References (24)

1. GLOBOCAN. International Agency for Research on Cancer website. http://globocan.iarc.fr/. Accessed April 1, 2013.
2. Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol. 2005;12:637-645. (Pubitemid 41126093)
3. Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol. 2004;22:3475-3484. (Pubitemid 41103653)
4. Clinical practice guidelines in oncology colon cancer v32013 & rectal cancer v42013. The National Comprehensive Cancer Network (NCCN) website. http://www.nccn.org/. Accessed April 1, 2013.
5. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol. 1999;6:651-657.
6. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg. 2003;196:722-728. (Pubitemid 36560202)
7. Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg. 2005;92:1155-1160. (Pubitemid 41284882)
8. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27:3379-3384.
9. Seo GJ, Park JW, Yoo SB, et al. Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer. J Surg Oncol. 2010; 102:94-99.
10. McCahill LE, Yothers G, Sharif S, et al. Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. J Clin Oncol. 2012;30: 3223-3228.
11. Rahbari NN, Lordick F, Fink C, et al. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS, a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer. 2012;12:142.
12. The role of surgery of the primary tumor with few or absent symptoms in patients with synchronous unresectable metastases of colon cancer, a randomized phase III study. Dutch Colorectal Cancer Group DCCG website. http://www.dccg.nl/newsletters. Accessed April 1, 2013.
13. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291:2441-2447. (Pubitemid 38669187)
14. I nternational Union Against Cancer. TNM Classification of Malignant Tumors. 7th ed. New York, NY: Wiley-Blackwell; 2009.
15. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-196.
16. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706. (Pubitemid 29126745)
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
18. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
19. Cox DR. Regression models and life-tables. J R Stat Soc Ser B. 1972;34:187-220.
20. Ballian N, Mahvi DM, Kennedy GD. Colonoscopic findings and tumor site do not predict bowel obstruction during medical treatment of stage IV colorectal cancer. Oncologist. 2009;14:580-585.
21. Okines A, Puerto OD, Cunningham D, et al. Surgery with curative- intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial. Br J Cancer. 2009;101:1033-1038.
22. Van Custem E, Bokemeyer C, Heeger S, Sartorius U, Rougier P, Kohne C. Outcome according to metastatic site in patients with KRAS wild-type tumors: Analysis from the CRYSTAL and OPUS studies. J Clin Oncol. 2011;29(suppl 4):472 [abstract].
23. Faron M, Bourredjem A, Pignon JP, et al. Impact on survival of primary tumor resection in patients with colorectal cancer and unresectable metastasis: Pooled analysis of individual patients' data from four randomized trials. J Clin Oncol. 2012;30(suppl): 3507 [abstract].
24. Schwenk W, Haase O, Neudecker J, Muller JM. Short term benefits for laparoscopic colorectal resection. Cochrane Database Syst Rev. 2005;(3):CD003145.